Impact of dabigatran on routine and specific coagulation assays in patients treated by dabigatran.

被引：0
|
作者：
Gemen, E. [1 ]
Kariman, A. [1 ]
Van Dijk, J. [1 ]
Van Eck, M. [1 ]
Pequeriaux, N. [1 ]
机构：
[1] Jeroen Bosch Hosp, Shertogenbosch, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 702
页数：2
相关论文
共 50 条
  • [41] Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide
    Siriez, Romain
    Evrard, Jonathan
    Dogne, Jean-Michel
    Pochet, Lionel
    Gheldof, Damien
    Chatelain, Bernard
    Mullier, Francois
    Douxfils, Jonathan
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (07) : 1203 - 1214
  • [42] Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
    Antovic, Jovan P.
    Skeppholm, Mika
    Eintrei, Jaak
    Boija, Elisabet Eriksson
    Soderblom, Lisbeth
    Norberg, Eva-Marie
    Onelov, Liselotte
    Ronquist-Nii, Yuko
    Pohanka, Anton
    Beck, Olof
    Hjemdahl, Paul
    Malmstrom, Rickard E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (11) : 1875 - 1881
  • [43] The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays
    Kim, Y. A.
    Gosselin, R.
    Van Cott, E. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (04) : e81 - e84
  • [44] Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation
    Seeger, John D.
    Bykov, Katsiaryna
    Bartels, Dorothee B.
    Huybrechts, Krista
    Zint, Kristina
    Schneeweiss, Sebastian
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1277 - 1289
  • [45] Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
    Jovan P. Antovic
    Mika Skeppholm
    Jaak Eintrei
    Elisabet Eriksson Boija
    Lisbeth Söderblom
    Eva-Marie Norberg
    Liselotte Onelöv
    Yuko Rönquist-Nii
    Anton Pohanka
    Olof Beck
    Paul Hjemdahl
    Rickard E. Malmström
    European Journal of Clinical Pharmacology, 2013, 69 : 1875 - 1881
  • [46] Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice
    Thorne, K.
    Jayathissa, S.
    Dee, S.
    Briggs, N.
    Taylor, J.
    Reid, S.
    De Silva, K.
    Dean, J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (03) : 261 - 265
  • [47] MANAGEMENT OF GASTROINTESTINAL SYMPTOMS IN PATIENTS TREATED WITH DABIGATRAN ETEXILATE (PRADAXA®)
    O'Dea, D. J.
    Sanganalmath, S. K.
    Schnee, J.
    Whetteckey, J.
    Ting, N.
    Duffy, C.
    CARDIOLOGY, 2015, 131 : 401 - 401
  • [48] Myocardial Ischemic Events in 'Real World' Patients Treated with Dabigatran
    Shah, Rahman
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (10): : E19 - E19
  • [49] Platelet reactivity monitoring in patients with atrial fibrillation treated with dabigatran
    Kalantzi, K.
    Tsoumani, M.
    Pappas, K.
    Tatsidou, P.
    Goudevenos, J.
    Tselepis, A.
    EUROPEAN HEART JOURNAL, 2013, 34 : 95 - 95
  • [50] Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update
    Xu, Ke
    Chan, Noel C.
    Eikelboom, John W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (09) : 1091 - 1102
12345